1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > 2016 Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

VPGMarketResearch.com presents a new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Worldwide Market Overview

- Five-year test volume and sales projections by country.

- Comprehensive market segmentation analysis, including review
of the market dynamics, structure, size, growth and major suppliers
by country.

- Estimated universe of laboratories performing cancer diagnostic testing
by country.

- Cancer statistics, etiology and recent developments in the
U.S., Europe, and Asia.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially
significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Hormones
- Immunohistochemical Stains
- Lymphokines

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major cancer diagnostic product
suppliers by individual test and country.

- Five-year test volume and sales forecasts
for major tumor markers by country and market segment, including:

     º  Hospitals
     º  Commercial/Private Laboratories
     º  Physician Offices/Group Practices
     º  Cancer Clinics
     º  Ambulatory Care Centers

Instrumentation Review

- Analysis of major molecular diagnostic and immunodiagnostic analyzers
used for cancer testing, including their operating characteristics,
features and selling prices.

Technology Assessment

- Assessment of latest technologies
and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies.

- Extensive listings of companies, universities
and research centers developing new cancer diagnostic tests
and detection technologies.

Competitive Strategies

- Strategic assessments of major suppliers
and start-up firms developing innovative cancer diagnostic
technologies and products, including their sales,
product portfolios, marketing tactics, collaborative
arrangements, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott
   - AdnaGen
   - Agilent Technologies
   - Applied Gene Technologies
   - Arca Biopharma
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - Biomedical Diagnostics
   - bioMerieux
   - Bio-Rad
   - CellSearch
   - Cepheid
   - Correlogic Systems/Vermillion
   - Decode Genetics
   - Diadexus
   - Diagnocure
   - DiaSorin
   - Eiken Chemical
   - Elitech Group
   - Enterix
   - Enzo Biochem
   - Epigenomics
   - Exact Sciences
   - Fujirebio
   - Guided Therapeutics
   - Hologic/Gen-Probe
   - Kreatech/Leica
   - Kyowa Medex
   - Mackay Life Sciences
   - Myriad Genetics
   - OncoLab
   - Ortho-Clinical Diagnostics
   - Panacea Pharmaceuticals
   - Polartechnics
   - Polymedco
   - PreMD
   - Qiagen
   - Quest Diagnostics
   - Radient Pharmaceuticals
   - Roche
   - Scienion
   - Sequenom
   - Siemens Healthcare
   - Takara Bio
   - Targeted Diagnostics & Therapeutics
   - Thermo Fisher
   - Tosoh
   - Veridex
   - Wako Pure Chemicals
   - Wallac/PE
   - Zilla/Alere

Contains 1,200 pages and 450 tables

Table Of Contents

2016 Cancer Diagnostics Market: Supplier Shares, Country Volume and Sales Segment Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, US
Table of Contents
I. Introduction

II. Worldwide Technology and Market Overview
A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
1. Blood Typing and Grouping Tests a. ABO b. Antibody Panels c. Antibody Screening d. Antigen Typing e. Antiglobulin Test f. Crossmatch g. HLA Typing h. Rh i. Other Blood Groups 2. Blood Group Genotyping a. PCR b. PCR-RFLP c. AS-PCR or PCR-SSP d. Multiplex PCR e. Real Time PCR f. Sanger DNA Sequencing g. Pyrosequencing b. Microarrays - BeadChip Array - BloodChip - Genome Lab SNP Stream - Fluidic Microarray Systems - TaqMan OpenArray - MALDI-TOF-MS - Mini-Sequencing 3. Infectious Disease Screening Tests a. AIDS - Structure and Composition - Classification - Origin of AIDS - Animal Lentivirus Systems - Virus Receptors

- HIV Infections in Humans -Pathogenesis and Pathology -Overview of Course of HIV Infection - CD4T Lymphocytes and Memory Cells - Monocytes and Macrophages - Lymphoid Organs - Neural Cells - Viral Coinfections -Clinical Findings - Plasma Viral Load - Pediactric AIDS -Neurologic Disease -Opportunistic Infections -Protozoa -Fungi -Bacteria - Viruses - Cancer - Immunity - Laboratory Diagnosis -Virus Isolation -Serology -Detection of Viral Nucleic Acid or Antigens - Epidemiology -Worldwide Spread of AIDS -United States -Routes of Transmission - Prevention, Treatment, And Control -Antiviral Drugs -Vaccines Against HIV - Transmission of HIV in Blood Products - HIV Transmission in Transplant and Artificial Insemination Recipients - Diagnostic Tests - Enzyme Immunoassay Interpretation - Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay - Competition Assays - Western Blot Technique - Immuno-Fluorescence Assay (IFA) - Radioimmunoprecipitation - HIV-1/HIV-2 Combination Testing

- Methods of HIV-Antigen Detection - Antigen Assays and Blood Screening - Urine Tests - DNA Probes - Overview - Quantitative Polymerase Chain Reaction - In Situ PCR - Needed Improvements - Viral Load/Drug Resistance Testing - Genotype and Phenotype Testing - Blood Banking Considerations b. Hepatitis - Hepatitis A - Hepatitis B -Structure and Composition -Replication of Hepatitis B Virus - Hepatitis C - Hepatitis D (Delta Hepatitis) - Hepatitis E - Hepatitis G - Hepatitis Virus Infections In Humans -Pathology - Clinical Findings - Laboratory Features -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis D -Hepatitis E - Virus-Host Immune Reactions - Epidemiology -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis D (Delta Agent) - Vaccines and Drugs c. Cytomegalovirus - Background - Chorioretinitis - Gastrointestinal

- Central Nervous System Disease - Diagnostic Tests - Vaccines and Drugs d. Syphilis - Background - Diagnostic Tests - Vaccines and Drugs e. West Nile Virus - Background - Clinical Syndromes - Diagnostic Tests - Vaccines and Drugs f. Parvovirus B19 - Microbiology - Epidemiology - Clinical Syndromes -Erythema Infectiosum Slapped (cheek) -Adult Polyarthropathy -Transient Aplastic Crisis -Transient Pancytopenia -Red Cell Aplasia in the Immunocompromised -Perinatal Infections - Diagnosis - Treatment g. Creutzfeldt-Jakob's Disease - Background - Transmission - Diagnostic Tests - Major Commercial and Academic Players -Bayer -Disease Sciences/BioTec Global -Imperial College School of Medicine -Ortho-Clinical Diagnostics -Pall -ProMetic Life Sciences -Proteome Sciences/Idexx -Q-One Biotech -Serono -U.S. Agricultural Research Service

- Drugs - Vaccines h. Malaria i. Chagas Disease j. Babesiosis 4. Pathogen Reduction 5. Leukocyte Reduction - Background - Methods B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured by:
- Abbott - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - BioMerieux - Cepheid - Curtis Unyvero - Gen-Probe/Hologic - GenMark - Grifols - HTG - Immucor - Life Technologies - Nanosphere - Ortho-Clinical Diagnostics - Qiagen - Roche - Sarstedt - Siemens - Tecan C. Major in Vitro Diagnostic Technologies And Their Potential Applications
1. Molecular Diagnostics a. Overview b. NAT 2. Monoclonal and Polyclonal Antibodies 3. Immunoassays a. Technological Principle b. Chemiluminescence

c. Enzyme Immunoassays (EIA) - Overview - ELISA - EMIT - Electrochemical d. Radioimmunoassays (RIA) e. Immunoprecipitation f. Affinity Chromatography 4. Microtitration Plates 5. IT and Automation 6. Lasers 7. Robotics 8. Synthetic Red Cell Substitutes 9. Genetically Engineered Blood Components a. Albumin b. Factor VIII c. Alpha-2 Antiplasmin d. Antithrombin III e. Factor IX f. Von Willebrand's Factor g. Fibrinogen h. t-PA 10. Blood Preservation 11. Autologous Blood Transfusion/Freezing
III. U.S. A. Executive Summary B. Business Environment C. Market Structure D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests

IV. Major Product Development Opportunities
A. Molecular Blood Typing and Grouping B. Infectious Disease Screening C. Auxiliary
V. Alternative Market Penetration Strategies
A. Internal Development B. Collaborative Arrangements C. University Contracts
VI. Potential Market Entry Barriers and Risks
A. Market Maturity B. Cost Containment C. Competition D. Technological Edge and Limitations E. Patent Protection
VII. Competitive Assessments
- Abbott - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - CellMark Forensics/LabCorp - Diagast - DiaSorin - Fujirebio - Hologic/Gen-Probe - Grifols - Immucor - Ortho-Clinical Diagnostics - Proteome Sciences - Quest Diagnostics - Quidel - Roche - Siemens - Tecan - Thermo Fisher

List of Tables
Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Executive Summary Table: U.S.A., Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
U.S.A., Estimated Number of Inpatient and Ambulatory Surgeries
U.S.A., Facilities Performing Blood Bank Tests by Market Segment
U.S.A., Hospital Laboratories Performing Blood Bank Tests by Bed Size
U.S.A., Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume Forecast
U.S.A., Facilities Collecting Whole Blood And Plasma by Market Forecast Segment

List of Tables (continued)
U.S.A., Whole Blood and Plasma Collections By Market Forecast Segment
U.S.A., All Market Segments Blood Typing and Grouping Test Volume by Market Forecast Segment
U.S.A., All Market Segments Blood Typing And Grouping Test Volume Forecast
U.S.A., Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Test Volume Forecast
U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Test Volume Forecast
U.S.A., Military Blood Banks Blood Typing and Grouping Test Volume Forecast
U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast By Market Segment
U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast
U.S.A., Community and Regional Centers Infectious Disease Screening Test Volume Forecast
U.S.A., Plasma Fractionation Centers Infectious Disease Screening Test Volume Forecast
U.S.A., Hospital Blood Banks Infectious Disease Screening Test Volume Forecast

List of Tables (continued)
U.S.A., Military Blood Banks Infectious Disease Screening Test Volume Forecast
U.S.A., All Market Segments Blood Typing And Grouping Reagent Market Forecast by Market Segment
U.S.A., All Market Segments Blood Typing And Grouping Reagent Market Forecast by Market Segment
U.S.A., Hospital Blood Banks Blood Typing And Grouping Reagent Market Forecast by Major Test
U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Reagent Market Forecast By Major Test
U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Reagent Market Forecast By Major Test
U.S.A., Military Blood Banks Blood Typing And Grouping Reagent Market Forecast by Major Test
U.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market Forecast Segment
U.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market Forecast Segment
U.S.A., Community and Regional Centers Infectious Disease Screening Reagent Market Forecast By Test

List of Tables (continued)
U.S.A., Plasma Fractionation Centers Infectious Disease Screening Reagent Market Forecast By Test
U.S.A., Hospital Blood Banks Infectious Disease Screening Reagent Market Forecast By Test
U.S.A., Military Blood Banks Infectious Disease Screening Reagent Market Forecast By Test
U.S.A., Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier
U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier
U.S.A., Hepatitis C Blood Screening Market, Reagent Sales By Major Supplier
U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales By Major Supplier
U.S.A., West Nile Virus NAT Market, Reagent Sales by Major Supplier
U.S.A., CMV Blood Screening Market, Reagent Sales by Major Supplier
U.S.A., Syphilis Blood Screening Market, Reagent Sales by Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Pathology Statistics in Zambia

  • December 2016
    13 pages
  • Pathology  

  • Zambia  

View report >

Infectious Disease Statistics in the US

  • December 2016
    32 pages
  • Infectious Dise...  

    Asthma  

  • United States  

View report >

Infectious Disease Statistics in Africa

  • December 2016
    3 pages
  • Infectious Dise...  

    Therapy  

    Pharmaceutical  

  • Africa  

    World  

View report >

Related Market Segments :

Infectious Disease

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.